Kosmeder JW - Search Results

1

In vitro assessment of intestinal permeability and hepatic metabolism of 4'-bromoflavone, a promising cancer chemopreventive agent.

Li Y, Grubjesic S, Nikolic D, Zhu D, Kosmeder JW, Moriarty RM, Pezzuto JM, Van Breemen RB. Li Y, et al. Among authors: kosmeder jw. Xenobiotica. 2004 Jun;34(6):535-47. doi: 10.1080/00498250410001713159. Xenobiotica. 2004. PMID: 15277014

2

Human, rat, and mouse metabolism of resveratrol.

Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. Yu C, et al. Among authors: kosmeder jw. Pharm Res. 2002 Dec;19(12):1907-14. doi: 10.1023/a:1021414129280. Pharm Res. 2002. PMID: 12523673

3

Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism.

Li Y, Shin YG, Yu C, Kosmeder JW, Hirschelman WH, Pezzuto JM, van Breemen RB. Li Y, et al. Among authors: kosmeder jw. Comb Chem High Throughput Screen. 2003 Dec;6(8):757-67. doi: 10.2174/138620703771826865. Comb Chem High Throughput Screen. 2003. PMID: 14683481 Review.

4

Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes.

Song LL, Kosmeder JW 2nd, Lee SK, Gerhäuser C, Lantvit D, Moon RC, Moriarty RM, Pezzuto JM. Song LL, et al. Among authors: kosmeder jw 2nd. Cancer Res. 1999 Feb 1;59(3):578-85. Cancer Res. 1999. PMID: 9973203

5

Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.

Yu C, Shin YG, Kosmeder JW, Pezzuto JM, van Breemen RB. Yu C, et al. Among authors: kosmeder jw. Rapid Commun Mass Spectrom. 2003;17(4):307-13. doi: 10.1002/rcm.918. Rapid Commun Mass Spectrom. 2003. PMID: 12569440

6

Cancer chemopreventive activity of sulforamate derivatives.

Moriarty RM, Naithani R, Kosmeder J, Prakash O. Moriarty RM, et al. Eur J Med Chem. 2006 Jan;41(1):121-4. doi: 10.1016/j.ejmech.2005.10.002. Epub 2005 Nov 21. Eur J Med Chem. 2006. PMID: 16300858

7

Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent.

Gerhauser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC, Pezzuto JM. Gerhauser C, et al. Among authors: kosmeder jw. Cancer Res. 1997 Aug 15;57(16):3429-35. Cancer Res. 1997. PMID: 9270009

8

Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats.

Udeani GO, Zhao GM, Shin YG, Kosmeder JW 2nd, Beecher CW, Kinghorn AD, Moriarty RM, Moon RC, Pezzuto JM. Udeani GO, et al. Among authors: kosmeder jw 2nd. Cancer Chemother Pharmacol. 2001 Mar;47(3):263-8. doi: 10.1007/s002800000187. Cancer Chemother Pharmacol. 2001. PMID: 11320671

9

Novel plant-derived anticarcinogens.

Kosmeder JW 2nd, Pezzuto JM. Kosmeder JW 2nd, et al. IARC Sci Publ. 2002;156:343-7. IARC Sci Publ. 2002. PMID: 12484202 Review. No abstract available.

10

Effect of deguelin on UVB-induced skin carcinogenesis.

Gills JJ, Kosmeder J 2nd, Moon RC, Lantvit DD, Pezzuto JM. Gills JJ, et al. J Chemother. 2005 Jun;17(3):297-301. doi: 10.1179/joc.2005.17.3.297. J Chemother. 2005. PMID: 16041863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page